IVN-CAT-001A Performance of CAST With Different Allergens in Patients With Cat Dander Allergy

This study has been completed.

First Received: February 11, 2008 Last Updated: November 19, 2008 History of Changes

Sponsors and Collaborators:	University of Zurich ImVision AG
Information provided by:	University of Zurich
ClinicalTrials.gov Identifier:	NCT00620880

Purpose

Primary objective of the trial:

To determine at which concentration the fusion protein MAT Fel d1 degranulates basophils of cat dander allergic patients, in comparison to a cat dander extract and to Fel d1 alone

Condition	Intervention
Allergy to Cats	Behavioral: Blood sample

Study Type:	Observational
Study Design:	Prospective
Official Title:	Performance of CAST With Different Allergens in Patients With Cat Dander Allergy

Resource links provided by NLM:

MedlinePlus related topics: Allergy

U.S. FDA Resources

Further study details as provided by University of Zurich:

Study Start Date:	September 2005
Study Completion Date:	September 2006

Eligibility

Ages Eligible for Study:	18 Years to 75 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion criteria: 1. Patient with Cat Dander Allergy evidenced by positive history 2. Age: 18 to 75 years

Exclusion criteria: 1. Use of oral corticosteroids, Chromoglycin, Ketotifen, or any immunosuppressive drugs within the last 2 months 2. Psychiatric disorder resulting in malcompliance 3. Neg. IgE to Cat dander

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00620880

Locations

Switzerland

Zurich, Switzerland

Sponsors and Collaborators

University of Zurich

ImVision AG

Investigators

Study Director:

01 Studienregister MasterAdmins

UniversitaetsSpital Zuerich

More Information

No publications provided

Responsible Party:	University of Zurich ( University Hospital Zürich )
Study ID Numbers:	IVN-CAT-001A
Study First Received:	February 11, 2008
Last Updated:	November 19, 2008
ClinicalTrials.gov Identifier:	NCT00620880 History of Changes
Health Authority:	Switzerland: Swissmedic

Study placed in the following topic categories:

Hypersensitivity

Additional relevant MeSH terms:

Hypersensitivity
Immune System Diseases

ClinicalTrials.gov processed this record on September 04, 2009